Prestige Consumer Healthcare Inc. announced its financial results for the second quarter of fiscal 2025, reporting revenues of $283.8 million, which exceeded its previous outlook. Diluted earnings per share for the quarter stood at $1.09, marking a 2% increase compared to the prior year period.
The company demonstrated strong liquidity and financial management, with net cash provided by operating activities for the first six months of fiscal 2025 reaching approximately $125 million, an increase of about 13%. This robust cash generation enabled a reduction in debt by $75 million and the repurchase of $38 million in shares year-to-date.
Management reaffirmed its full-year fiscal 2025 revenue, earnings, and cash flow outlook, indicating confidence in the company's ongoing performance. These results highlight Prestige Consumer Healthcare's ability to deliver consistent financial performance and manage its capital effectively.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.